FcγRIIB regulation of BCR/TLR-dependent autoreactive B-cell responses.
Crosslinking of Fc γ receptor II B (FcγRIIB) and the BCR by immune complexes (IC) can downregulate antigen-specific B-cell responses. Accordingly, FcγRIIB deficiencies have been associated with B-cell hyperactivity in patients with systemic lupus erythematosus and mouse models of lupus. However, we have previously shown that murine IgG2a-autoreactive AM14 B cells respond robustly to chromatin-associated IC through a mechanism dependent on both the BCR and the endosomal TLR9, despite FcγRIIB coexpression. To further evaluate the potential contribution of FcγRIIB to the regulation of autoreactive B cells, we have now compared the IC-triggered responses of FcγRIIB-deficient and FcγRIIB-sufficient AM14 B cells. We find that FcγRIIB-deficient cells respond significantly better than FcγRIIB-sufficient cells when stimulated with DNA IC that incorporate low-affinity TLR9 ligand (CG-poor dsDNA fragments). AM14 B cells also respond to RNA-associated IC through BCR/TLR7 coengagement, but such BCR/TLR7-dependent responses are normally highly dependent on IFN-α costimulation. However, we now show that AM14 FcγRIIB(-/-) B cells are very effectively activated by RNA IC without supplemental IFN-α priming. These results demonstrate that FcγRIIB can effectively modulate both BCR/TLR9 and BCR/TLR7 endosomal-dependent activation of autoreactive B cells.
Avalos
Ana M
AM
Department of Microbiology, Boston University School of Medicine, Boston, MA 01655, USA. Ann.Rothstein@umassmed.edu
Uccellini
Melissa B
MB
Lenert
Petar
P
Viglianti
Gregory A
GA
Marshak-Rothstein
Ann
A
D000818:Animals; D000936:Antigen-Antibody Complex / Q000276:immunology; D001324:Autoantigens / Q000276:immunology; D015551:Autoimmunity / Q000276:immunology; D001402:B-Lymphocytes / Q000276:immunology*; D002450:Cell Communication / Q000276:immunology; D002460:Cell Line; D008213:Lymphocyte Activation; D051379:Mice; D018345:Mice, Knockout; D008822:Mice, Transgenic; D011947:Receptors, Antigen, B-Cell / Q000276:immunology*; D017452:Receptors, IgG / Q000276:immunology*; D013047:Specific Pathogen-Free Organisms; D051217:Toll-Like Receptor 9 / Q000276:immunology*
D000936:Antigen-Antibody Complex; D001324:Autoantigens; C499172:Fcgr2b protein, mouse; D011947:Receptors, Antigen, B-Cell; D017452:Receptors, IgG; D051217:Toll-Like Receptor 9
Science. 2005 Jan 28;307(5709):590-3
15681388
Nature. 2000 Dec 7;408(6813):740-5
11130078
J Immunol. 2009 Sep 1;183(5):3109-17
19648272
Nature. 1996 Jan 25;379(6563):346-9
8552190
J Immunol. 1997 Aug 1;159(3):1125-34
9233605
Mol Immunol. 2009 Jun;46(10):1970-8
19362372
J Immunol. 1991 Jul 1;147(1):361-8
1711083
Immunity. 2008 Mar;28(3):315-23
18342006
Arthritis Res Ther. 2009;11(3):R79
19476613
J Immunol. 1994 May 1;152(9):4489-99
8157964
Nature. 2002 Apr 11;416(6881):603-7
11948342
Science. 2004 Mar 5;303(5663):1529-31
14976261
Immunity. 2006 Jan;24(1):19-28
16413920
Science. 2002 Aug 9;297(5583):1031-4
12130661
J Exp Med. 2006 Sep 4;203(9):2157-64
16923849
Int Immunol. 2008 Feb;20(2):185-92
18182380
J Immunol. 2009 Aug 1;183(3):1569-76
19587008
J Immunol. 2007 Mar 1;178(5):3272-80
17312177
J Immunol. 2008 Nov 1;181(9):5875-84
18941176
Clin Immunol Immunopathol. 1988 Mar;46(3):382-95
3338196
J Immunol. 1992 Mar 1;148(5):1561-9
1371530
Science. 2004 Mar 5;303(5663):1526-9
14976262
J Immunol. 2009 Nov 15;183(10):6262-8
19864612
J Biol Chem. 1995 Jul 7;270(27):15938-41
7608146
Immunogenetics. 2000 May;51(6):429-35
10866109
Immunity. 2003 Dec;19(6):837-47
14670301
J Immunol. 1985 May;134(5):2835-8
3156919
Proc Natl Acad Sci U S A. 2004 Apr 13;101(15):5598-603
15034168
Immunity. 2000 Aug;13(2):277-85
10981970
Immunity. 2005 Jul;23(1):41-51
16039578
Curr Opin Genet Dev. 1995 Jun;5(3):309-14
7549424
J Exp Med. 2005 Nov 7;202(9):1171-7
16260486
J Biol Chem. 1994 Apr 15;269(15):11409-16
7512564
J Immunol. 2000 Aug 1;165(3):1626-33
10903773
Annu Rev Immunol. 2001;19:275-90
11244038